3 Undiscovered Stocks Set to Double Your Money

Group 1: Inseego (INSG) - Inseego leads in 5G and IoT solutions, achieving a non-GAAP gross margin of 38.7% in Q1 2024, marking one of its highest levels in seven quarters due to favorable product mix and operational efficiencies [3][4] - The company reported $12.3 million in cash as of Q1, a significant increase from the previous year, and terminated its Asset-Based Lending arrangement, enhancing liquidity and reducing interest costs [4] - Inseego's strategic focus on capital optimization and cost reduction positions it as a strong candidate for growth and profitability [4] Group 2: Oscar Health (OSCR) - Oscar Health, a technology-driven health insurance company, reported $177.4 million in net profits for Q1 2024, a $217.1 million increase year-over-year [6][7] - The company achieved an adjusted EBITDA of $219.3 million, reflecting a year-over-year rise of $168.2 million, indicating strong financial stability [6] - Oscar's selling, general, and administrative expenditure ratio decreased by 8.7% to 18.4%, while its medical loss ratio increased by 2.1% to 74.2%, showcasing effective management of healthcare expenses [7] Group 3: Acacia Research (ACTG) - Acacia Research reported an EPS of 6 cents in Q1 2024, indicating potential profitability after non-recurring costs, with an operating loss improvement from $9.3 million in Q1 2023 to $2.1 million [8][9] - The company held over $400 million in cash and marketable securities as of Q1, providing flexibility for expansion opportunities [9] - Acacia Research maintains a cautious debt profile with total non-recourse debt at $13.0 million and a sound balance sheet structure, highlighted by a $28.6 million realized gain from the sale of Arix Bioscience [9]